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ABSTRACT
The relationship of olfactory functioning and hormones is complex, and, for the most part,
heterogenous. The present study aims to clarify and or define aspects of this relationship by
examining how olfactory thresholds fluctuate in relation to changing hormone levels in two
populations: menstruating and pregnant women. A longitudinal study was implemented to assess
women at two different times. A total of 72 non-pregnant and 7 pregnant women participated in
the first assessment, with a total of 62 non-pregnant and all 7 pregnant women returning for the
second assessment. During each examination participants had blood drawn and were
administered a threshold test. The Wheeler-University of Tennessee at Chattanooga odor
threshold test (WUTC) allowed for the measurement of odorant sensitivity of 4 distinct odorants.
Hormone levels were analyzed using a method of gradient high-performance liquid
chromatography (HPLC). Multiple analyses yielded a conclusion that the changes in estrogen
levels influence olfactory ability to an extent that as estrogen levels increase throughout the
menstrual cycle or peak during the first trimester of pregnancy, olfactory ability is significantly
heightened (p<.05). This research has provided evidence supporting the idea that hormone levels
do influence olfactory ability fluctuation during the menstrual cycle and in portions of
pregnancy.
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CHAPTER I
INTRODUCTION
As human beings, perception of the environment is based on the sensory information
provided by external stimuli to the five senses. Sight is a product of electromagnetic radiation
filtering to the retinas in the eyes. The sense of touch is stimulated by the resulting pressure from
physical contact to an object. Fluctuations in air pressure result in perceiving different sounds.
The chemical nature in the surroundings informs the senses of taste and smell. These two senses
are chemically influenced by the most common environmental component – air. Yet, the
research of these two senses, particularly that of olfaction, is comparatively limited.
Beyond the external, internally there are multiple facets that influence our perception of
the environment. One of the major influences of bodily function, and therefore a dominant
contributor to the perceived world around us is hormones. Hormones, both in type and amount,
can and do dictate many changes within the body, possibly even, changes in the ability to smell.

Menstrual Cycle
The possible influence of hormonal state on olfactory function has long been an interest
of researchers (Doty, Deems & Stellar, 1988). This interest has led to several studies
investigating olfactory perception during natural states of hormonal fluctuation and the menstrual
cycle.
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Researchers have since studied the menstrual cycle in depth and examined it in a variety
of ways. Across various studies the menstrual cycle has been divided into two (e.g., Hertz &
Jensen, 1975), three (e.g., Englander-Golden, Change, Whitmore & Dienstbier, 1980), four (e.g.,
Graham & Sherwin, 1993), five (e.g., Hart, 1960), and six (e.g., Bancroft, Sanders, Davidson &
Waller, 1983) phases. In the current study, four phases of the menstrual cycle will be
differentiated: follicular phase, ovulation, luteal phase and menses.
During the menstrual cycle the female body undergoes a variety of changes including
fluctuations in basal body temperature (Church, Hedricks, LeFevre & McClintock, 1994) and
hormone levels (Wallen & Zehr, 2004). In healthy females, gonadal hormone alterations occur
in a cyclic fashion, changing from phase to phase throughout the menstrual cycle. The basal
body temperature, rising and falling as a result of hormonal fluctuation also follows a cyclic
pattern (Church et al., 1994). During the first phase of menstruation, the follicular phase,
estrogen exponentially rises to a peak level relative to each individual’s baseline. If the basal
body temperature changes during the follicular phase, a decrease within half a degree will be
measured. The relatively high levels of estrogen cause a surge of two hormones: luteinizing
hormone and follicle-stimulating hormone. The spike of these two hormones indicates the
second phase, ovulation. Upon ovulation, completion estrogen, luteinizing and folliclestimulating hormones drop and return to baseline. Through the development of the third phase,
the luteal phase, progesterone increases, up to tenfold, and remains consistently high throughout
the phase. A rise in estrogen occurs, however, levels do not peak rapidly, nor do they surpass
those of progesterone. It is after ovulation, when progesterone is rising, that basal body
temperatures tend to increase up to a degree and a half above an individual’s baseline. At the
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onset of the fourth phase of the menstrual cycle, menses, both estrogen and progesterone levels
have dropped back to baseline (Reichman, 2009).

Phase Classification
Studies investigating changes in olfactory perception throughout the menstrual cycle
typically contribute the changes observed to the phase of menstruation and/or to hormonal
fluctuations. To determine the phase of menstruation investigations have used one of five
methods: self-report of menstrual cycle (e.g., Graham & Sherwin, 1993), measurement of basal
body temperature (e.g., Watanabe, Umezu & Kurahashi, 2002), characteristics of cervical mucus
(e.g., Church et al., 1994), urine analysis to determine levels of luteinizing hormones (e.g.,
Lundstrom,	
  McClintock & Olsson, 2006), or blood analysis (e.g., O’Leary, Boyne, Flett, Beilby
& James, 1991).

Olfactory Abilities
Upon menstrual phase classification researchers have attempted to understand the
relationship of the phase of the menstrual cycle and possible changes in olfaction. In general,
results determining a relationship are heterogeneous. It is proposed that olfactory sensitivity
increases during ovulation and the luteal phase (Doty, Hall, Flickinger & Sondheimer, 1982;
Doty, Snyder, Huggins & Lowry, 1981; Le Magnen, 1952; Vierling & Rock, 1967; Mair,
Bouffard, Engen & Morton, 1978; Navarrete-Palacio, Hudson, Reyes-Guerrero & GuevaraGuzman, 2003), and decreases during menses (Good, Geary & Engen, 1976; Le Magnen, 1952;
Mair et al., 1978; Moriyama & Kurahashi, 2000; Navarrete-Palacios et al., 2003; Schneider &
Wolf, 1955). However, there are conflicting studies. Koster (1968) concluded that olfactory
3

sensitivity improves just before and during menses, while Henkin (1974) found that
hypersensitivity occurs only during the follicular phase of the menstrual cycle. Derntl, Schopf,
Kollndorfer and Lanzenberger (2012) reported increased olfactory sensitivity to occur only
during the luteal phase. Furthermore, several studies have concluded that there are no menstrual
cycle-dependent alterations in olfaction (Amoore, 1974; Filsinger & Monte, 1986; Herberhold,
Genkin, Brandle, Leitner & Wollmer, 1982; Hummel, Gollisch, Wildt & Kobai, 1991; Hummel,
Kobal, Gudziol & Mackay-Sim, 2007; Kanamura & Takashima, 1991).

The Possible Other Use of Oral Contraceptives
Few studies have attempted to directly correlate hormone level fluctuations during the
menstrual cycle with olfactory changes. As previously discussed, the determination of a
relationship between the phase of the menstrual cycle and changes in olfactory sensitivity is
confused and inconclusive. The measurement of hormone levels has served more as a means of
phase classification without the continual application and investigation of varying hormone level
fluctuations and alterations of olfactory sensitivity. Rather, research has moved towards the
investigation of the impact of oral contraceptives.
Oral contraceptives affect the human body in varying ways. Most commonly, oral
contraceptives artificially provide heightened hormone levels to keep the body in a stall state.
Typically progesterone is the primary component of oral contraceptives. This allows the body to
remain in a simulated luteal phase until the hormone levels drop. Some oral contraceptives more
closely mimic the body’s natural menstrual cycle providing a biphasic hormone administration of
estrogen and progesterone.
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Caruso, Grillo, Agnello, Maiolino, Intelisann, and Serra (2001) and Doty et al. (1981)
compared the changes of olfactory sensitivity of oral contraceptive users and non-users. The oral
contraceptive users were taking a monophasic pill intended to mimic the luteal phase by
maintaining relatively high levels of progesterone up until the day of ovulation. It was concluded
that olfactory sensitivity mimicked that of oral contraceptive non-users (Caruso et al., 2001;
Doty et al., 1981), suggesting that changes in olfactory function during the menstrual cycle are a
result of something other than fluctuating hormone levels. Lundstrom, McClintock, and Olsson
(2006) found that oral contraceptive users experienced greater olfactory sensitivity when
inhaling social odors (e.g., androstadienone) and a decrease in sensitivity when inhaling
environmental odors (e.g., rose).

The Pregnant Nose
As research has progressed and the relationship between hormones and olfaction has
become more complex, the interests have spread to the investigation of olfactory differences
during pregnancy, the results of which are, to some extent, contradictory (Laska, Koch, Heid &
Hudson, 1996). Overall a majority of pregnant women self-report changes in odor perception
during pregnancy (Ochsenbein- Kölble, von Mering, Zimmermann & Hummel, 2007;
Wohlgemuth, Beinder, Ochsenbein-Kölble & Hummel, 2008). While considerable anecdotal
evidence suggests that pregnant women, when compared to non-pregnant women, are more
sensitive to odors, objective measurement of this sensitivity is limited and inconclusive. Some
studies have presented evidence suggesting hypersensitivity during pregnancy (Broman,
Olofsson, Olsson & Nordin, 2003; Lundström, McClintock & Olsson, 2006; Nordin, Broman,
Bringlöv & Wulff, 2004). Yet other studies have concluded that during pregnancy there is no
5

olfactory hypersensitivity (Laska & Teubner, 1999; Swallow et al., 2005). Furthermore, some
studies have found hyposensitivity to pervade during pregnancy, while a few have reported the
occurrence of anosmia (Cameron, 2007).
Various studies reporting a change in olfactory sensitivity differ concerning the
description of the time of maximum effect (Laska et al., 1996). Le Magnen (1952) concludes
that pregnant women experience an increase in odor sensitivity during the first trimester, while
Good, Geary and Engen (1976) stipulate hypersensitivity to occur predominantly throughout the
second and third trimesters. Very few studies have emphasized or even included the third
trimester of pregnancy during investigation (Ochsenbein-Kölble et al., 2007). Of these, some
investigators report a decreased sensitivity later in pregnancy when compared to non-pregnant
controls (e.g. Laska et al., 1996; Wohlgemuth et al., 2008), while Nordin, Broman, Bringlöv and
Wulff (2007) specify that changes in olfactory sensitivity rarely occur late in pregnancy.

Odor Sensitivity
It should be noted that the aforementioned studies differ in the operational definition of
odorant sensitivity. For example, Nordin et al. (2004) write of sensitivity in relation to odor
identification, whereas Laska et al. (1996) discuss sensitivity in terms of ability to sense the
presence of any odor. The current study refers to sensitivity as the latter. Before a certain
threshold there should be no odorant detection. Above its threshold, the perception of an odor
increases in magnitude relative to the increase of odor concentration (Walker, Hall, Walker,
Kendal-Reed, Hood & Niu, 2003).
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Evolution Could Be the Key
The potential changes in olfaction sensitivity during pregnancy could be due to
strengthened hormonally modulated connections between the limbic system and the olfactory
system (Cameron, 2007; Wohlgemuth et al., 2008), or this resulting effect could be in response
to changes in the cognitive information processing of odorants (Kölble, Hummel, von Mering,
Huch & Huch, 2001; Zou, Li & Buck, 2005). Cameron (2007) postulates that the foundation for
odor detection may be more drastic during pregnancy. That is to say that a small change in odor
concentration that may go unnoticed by non-pregnant women might result in a large change in
odor intensity perception for pregnant women (Cameron, 2007). This enhanced odor sensitivity
could provide an evolutionary advantage, discouraging pregnant women from ingesting
potentially noxious substances that could be harmful to a developing fetus (Heinrichs, 2002;
Profet, 1992) or enriching the perceived attractiveness of a pregnant woman’s mate
(Wohlgemuth et al., 2008).
Evolutionarily female fertility, in large part dictated by the endocrine system’s regulation
of gonadal hormones, has evolved to emphasize certain hormonal phases (Wallen & Zehr, 2004).
During a normal, healthy pregnancy this regulation tends to develop in a uniform manner.
Studies have shown an increase in a multitude of hormones in varying amounts throughout
pregnancy. These hormones include estradiol, progesterone, testosterone, sex-binding-hormone
globulin, androstenedione and 17-hydroxyprogesterone. A decrease in dehydroeplandrosterone
sulfate has also been reported (O’Leary et al., 1991).
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Neglected but Not Forgotten
The research conducted thus far examining the pregnant population has neglected the
consideration or the empirical measure of hormonal changes experienced by pregnant females
and how said changes influence olfaction. Hormonal fluctuations seemingly dictate much of the
olfactory perception change during the menstrual cycle. The hormone changes that occur during
pregnancy could exhibit the same type of influence over the olfactory system.
There is certain, albeit not entirely conclusive, support for the idea that pregnant women
perceive some odorous substances as stronger than do non-pregnant women (Nordin et al.,
2004). Also, as mentioned previously, Lundstrom et al. (2006) discussed evidence for women
taking oral contraceptives sense some odorants more readily than others.

The Present Study
The literature is suggestive but contradictory and inconclusive concerning the effects of
hormones on olfactory perception, particularly odorant sensitivity. The present study has been
designed to examine this effect based on specific odorants and measured olfactory ability.

Odorants
In the current study, four odorants will be used – vanillin, caraway, spearmint and
muscone – to assess olfactory ability. The odors were selected based on the diverse properties
they possess. The odors differ by their molecular classifications as well as in their perceived
qualities (e.g., sweet, pungent). The chemical formula and structure can be found in Appendix A.
Muscone is a non-polar, 15-carbon ring with a ketone functional group. Muscone is a
territorial pheromone in musk deer (Jacob, Garcia, Hayreh, & McClintock, 2002), and has an
8

odor similar to sweet, pungent fresh earth. The chemical structure of non-polar compounds
allows for the odorant to diffuse across the mucus membrane in the nose without the direct aid of
olfactory binding proteins. In addition, muscone has been chosen because, even in high
concentrations, it does not activate the trigeminal nerve (Jacob et al., 2002). Avoiding activation
of the trigeminal nerve ensures that only odorant sensitivity is assessed (Doty, 2001).
Vanillin, unlike muscone, is a polar molecule used in commercial products throughout
the United States. Vanillin exudes a characteristic pleasant, sweet aroma. It is also one of the first
odors to be recognized and preferred by infants (Edraki, Pourpulad, Kargar, Pishva, Zare &
Montaseri, 2013). Polar molecules require olfactory binding proteins to transport them across the
mucus membrane. If hormone levels affect the availability or binding process of the olfactory
binding proteins or olfactory binding receptors, examining the effects of both a polar and nonpolar molecules has the potential to lend insight.
Caraway and spearmint each contain an optical isomer, or enantiomer, carvone. The
enantiomers of carvone share an isopropenyl group at the chiral carbon, allowing for this
enantiomer to differ in odor quality (Bentley, 2006; Laska, 2004). Receptors in the body are
stereoselective and, as a result, typically react with only one of the compounds of an enantiomer
pair. Each enantiomer, due to three dimensional molecule arrangement differences, binds to the
odor receptors in a different and specific way, hence the different perception of spearmint and
caraway odors. R-(-)-carvone is perceived to have the fresh, minty odor quality synonymous
with spearmint, while the S-(+)-carvone odor is caraway and dill-like with a peppery undertone.
Carvone enantiomeric odor pairs have also been shown to not be mediated by the activation of
the trigeminal nerve (Laska & Teubner, 1999).
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The chirality of these enantiomers is an aspect of olfaction unexamined in the pregnant
population or within the context of the menstrual cycle. The perception of different odorant
properties for these two enantiomers lends support toward olfactory receptors containing chiral
groups that allow for a stronger response to one enantiomer compared to the other.

Hypotheses
The present study has been designed to examine the effect of hormones on the olfactory
abilities of women on four levels by using the four aforementioned odorants. The first level
examines olfactory perception across all trimesters of pregnancy, and the second is a comparison
of olfactory ability between two groups: pregnant and non-pregnant women. The third and
fourth levels of investigation are a comparison of the differences of odorant perception during
the menstrual cycle and during pregnancy. The hypotheses are as follows:
Hypothesis 1: Women will experience higher levels of olfactory sensitivity and have
lower threshold levels for all odorants as a result of increased estrogen levels.
Hypothesis 2: Overall, oral contraceptive users will have greater olfactory sensitivity and
lower thresholds while taking the active hormone pill when compared to oral contraceptive users
in menses.
Hypothesis 3: Olfactory abilities will decrease throughout pregnancy.
3a. Odorant thresholds will increase throughout pregnancy; therefore those at the
beginning of pregnancy will have lower odorant thresholds than those toward
the end of pregnancy.
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3b. Olfactory sensitivity will decrease throughout pregnancy; therefore olfactory
sensitivity will be higher at the beginning of pregnancy than toward the end of
pregnancy.
Hypothesis 4: Pregnant women will have a greater olfactory sensitivity, thus a lower
threshold, when compared to non-pregnant controls.

11

CHAPTER II
METHOD
The current study was conducted at two different time measurements. Assessment one
data was collected in late November, and assessment two data was collected in the middle of
December.

Participants
During part one of the assessment, 72 non-pregnant, female participants ages 18 to 43
years old (M=20.11, SD=3.388) and seven pregnant participants ages 29 to 41 (M=34.86,
SD=4.488) were recruited from the University of Tennessee at Chattanooga campus and a
medium size obstetrics and gynecology clinic in Chattanooga, Tennessee. Part two of the
experiment received a total of 62 of the original 72 non-pregnant participants ages 18-41
(M=20.21, SD=3.599) and all seven of the pregnant participants returning for assessment. An
overview of where each pregnant participant self-reported to be within pregnancy can be found
in Table 2.1. Also, a summary of self-reported ethnicities of non-pregnant participants can be
found in Table 2.2. It should be noted that each pregnant participant self-reported as Caucasian.
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Table 2.1 Pregnancy Trimester During Assessment
Participant
1
2
3
4
5
6
7

Trimester at
Assessment 1
1
1
1
2
2
2
3

Trimester at
Assessment 2
1
2
2
3
3
3
3

Table 2.2 Ethnicity of Non-Pregnant Participants at Assessment One and Two
Ethnicity
Caucasian
African American
Bi-Racial
Latina
Middle Eastern
Asian

Assessment 1
Frequency
51
10
5
3
2
1

Percent
70.83
13.89
6.94
4.17
2.78
1.38

Assessment 2
Frequency
44
9
4
2
2
1

Percent
70.97
14.52
6.45
3.22
3.22
1.61

Participants were asked to complete a demographic questionnaire (Appendix B) to
ascertain details about past and current health at both assessment one and two. Questions
concerned such things as smoking habits, past and current diseases and disorders, medications,
menstruation and pregnancy history. A depiction of this data is shown in Table 2.2 for both part
one and part two of the experiment. Upon completion of the second assessment, participants
were given a non-transferrable, fifteen-dollar gift card from a local business.
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Table 2.3 Health History Data for Non-Pregnant Participants at Assessment One and Two
Anemia	
  
Arthritis	
  
Asthma	
  
Bleeding/Clotting	
  Disorder	
  
Broken	
  Nose	
  
Cancer	
  
Chronic	
  Headaches	
  
Circulation	
  Problems	
  
Concussion/Head	
  Trauma	
  
Deviated	
  Septum	
  
Diabetes	
  
Epilepsy	
  
Eye	
  Disease	
  
Food	
  Allergies	
  
Gout	
  
Heart	
  Disease	
  
Hepatitis	
  

Time	
  1	
  

Hiatal	
  Hernia	
  

Time	
  2	
  

High	
  BP	
  
HIV	
  
Infection	
  
Kidney	
  Disease	
  
Lung	
  Trouble	
  
Medical	
  Allergies	
  
Neurological	
  Disease	
  
Seasonal	
  Allergies	
  
Sinus	
  Problems	
  
Skin	
  Disease	
  
Sleep	
  Apnea	
  
Stroke	
  
TB	
  
Thyroid	
  Disorder	
  
Ulcer	
  
Other	
  Medical	
  Illnesses	
  
0	
  

5	
  

10	
  

15	
  

14

20	
  

25	
  

30	
  

Review Board
The current study has been approved by the University of Tennessee at Chattanooga
Institutional Review Board (Appendix C). In compliance with this approval all data, including
blood analysis results, threshold data and demographic information were kept confidential and
stored in an encrypted data file.

Protection of Health Information
Prior to beginning data collection, all researches involved were required to complete
HIPPA training and become HIPPA certified. Also, researchers were required to complete NIH
and CITI certifications before having access to participant information collected during
assessment.

Materials and Procedures
Modification of the WUTC
The original Wheeler-University of Tennessee at Chattanooga (WUTC) threshold test
(Tewalt, 2013) contained five odorants: ethanol, L-α-pinene, vanillin, isoamyl acetate, and pcresol. For the current study, an odorant modified WUTC threshold test was used. Four distinct
odorants were selected in the modification of the WUTC threshold test: vanillin, R-(-)-carvone,
S-(+)-carvone, and muscone. Each of these odorants was selected for a distinct reason as
described previously.
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Odorant Dilutions
In making the modified WUTC threshold test, each odorant molecule was dissolved,
based on each molecule’s individual solubility, in a purified water solvent to create a maximum
concentration standard dilution that appeared to be visually translucent and clear. A 1:3
geometric serial dilution of the standard solution was used to create a total of nine concentrations
for each odorant. The dilutions were made to allow for the middle odorant tube to contain a
dilution equivalent to that of reported threshold detection norms. Ten milliliters of each dilution
were contained in a sterilized glass vial. Appearance of the liquid, regardless of odorant or
concentration, remained translucent and clear in nature. In total, the WUTC threshold test
contained nine varying concentrations of each of the four odorants for a total of thirty-six
odorant vials. In addition, nine non-odorous, “blank” vials were included. Blanks were made
using ten milliliters of purified water. The final, modified version of the WUTC threshold test
contained forty-five separate vials of varying concentrations of four odorants and blanks.

Threshold Test Administration
During parts one and two, participants completed the WUTC threshold test. At each
presentation of the threshold test, two researchers were present. Because carry over effects from
one assessment to the next can be an issue when assessing participants in a longitudinal fashion,
participants were informed that the tubes would be presented in a random order at each test
administration. Participants were also told that some tubes could have detectable odorants, some
could have odorants that might not be potent enough to perceive, and some could have no
odorant present. Once participants had read through and signed an informed consent specific to
the threshold test (Appendix D), they were asked to sit, facing away from the researchers.
16

Participants were randomly presented with 10mL of each dilution for a total of 5 seconds at a
distance of about 2 cm below the participant’s nose by a researcher using a test tube holder.
Upon retraction of the odorant dilution the participant was allowed 10 seconds to indicate, by
stating “yes” or “no”, if an odor had been detected. Out of the line of sight of the participant, a
second researcher recorded the indications appropriately. This second researcher was also
responsible for preparing the next tube in the randomized order for the administering researcher.
In this way the administration of the test tubes was double blind. The test was considered
complete when the participant had given a response for all odorant dilutions and blanks.

Blood Collection
Prior to completing the modified WUTC threshold test, blood was drawn from each
participant during both parts of the experiment for the purpose of ascertaining estrogen hormone
levels at the time of participation. Blood Assurance of Chattanooga agreed to draw 10 milliliters
of blood from each participant during parts one and two of the experiment. In cooperation with
Blood Assurance of Chattanooga, all non-pregnant participants were asked to attempt to donate
blood prior to the draw of the first required 10 milliliter sample, and each participant was
required to complete two informed consent forms, one specific to the 10 milliliters vial blood
draw as a part of the study (Appendix E) and one provided by the staff at Blood Assurance of
Chattanooga (Appendix F).
Blood withdrawals followed the standardized procedures set by Blood Assurance. After
the 10 milliliters of blood was drawn into a sealed, sterilized vial, each vial was labeled with a
six digit serial number. This vial number was then transferred to a master document and to the
participants’ specified threshold test response sheet for the purposes of linking any results
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obtained from the blood analysis to individual threshold data. Once the blood was obtained from
each participant for part one of the experiment it was stored at a constant temperature of -80
degrees Celsius for optimal preservation.
Three weeks after the completion of the first part of the experiment participants
completed the second portion of the research. This portion of the study mimicked the material
and procedures of part one, with the exception that no one was asked to donate blood prior to
their blood draw. After 10 milliliters of blood was obtained from each participant, each vial was
labeled with the same six digit serial number assigned to the participants during their
participation in part one as recorded on the master list. To identify which blood sample was
drawn first and which second for any given participant an 11 or 12 was recorded on the first and
second blood draw vials respectively. Once serial numbers were confirmed to match the master
list linking participants’ names to the blood vial, the master list of serial numbers was destroyed
to protect participant confidentiality.
A total of 148 blood samples (10 milliliters) were stored in a freezer at the University of
Tennessee at Chattanooga in the biochemistry lab.

Blood Analysis
The blood samples were analyzed through multiple procedures in randomized batches.
Four days prior to the start of blood analysis vials were selected from the freezer and placed in a
refrigerator. This allowed for the blood samples to slowly thaw to a temperature of 4 degrees
Celsius. Once thawed one milliliter aliquots of each sample were drawn from each vial using a
single, sterilized syringe and needle. The samples were subjected, six at a time, to
ultracentrifugation in a Centrifree Micropartition device with a 30,000 Dalton cut-off membrane
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at 2000 xg for 30 minutes. The filtrate samples were then diluted with purified methanol
(CH3OH ) to make a one milliliter mixture. Each diluted filtrate sample was then labeled with a
matched, six digit serial number and stored at 25 degrees Celsius prior to further analysis.
Standard solutions were made to contain single molecules of estradiol in varying
concentrations with methanol in order to verify the detection of estradiol molecules based on
determined retention time and corresponding peak height and area. After confirming detection
criteria the refrigerated filtrate mixtures were analyzed using a Reversed-Phase High
Performance Liquid Chromatography (HPLC) to separate the molecular components in the
mixture. The instrument was equipped with a stationary phase 250-millimeter x 4.6-millimeter
Porshell II (void volume of 1.5 milliliters); the mobile phase buffer used in separation was
HPLC-grade methanol. A five minute column pre-clean, using methanol, was performed prior to
each set of analyses. Also, the syringe was washed with methanol and HPLC-grade water prior
to each analysis to avoid cross-contamination.
The 15 microliter injection of each filtrate mixture was loaded onto the column and
subjected to elution for 5 minutes at a flow rate of 1milliliter/minute by the methanol buffer.
Component molecules of the filtrate mixture were detected by ultraviolet absorbance using a
deuterium lamp at wavelengths of 280 nanometers – the wavelength at which aromatic proteins
(e.g., estradiol) typically absorb. Because proteins also absorb at 214 nanometers, and organic
compounds, like estradiol, absorb at 254 nanometers, each of these wavelengths was also
observed. No significant differences were observed in the elution chromatograms at 214 or 254
nanometers compared to the detection profile at 280 nanometers.
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CHAPTER III
RESULTS
Analysis
Blood Analysis
To determine levels of estrogen in the blood of participants at the time of completing the
threshold test, samples were analyzed with an HPLC. Retention times and peaks at 280
nanometers for each sample were compared to that of the standard solutions also analyzed during
the same time period. The retention time as well as the peak areas recorded varied analysis to
analysis, requiring the standard solutions to be measured during each sample batch analysis. This
variation can be due to factors such as ambient pressure and temperature and fluctuating pressure
within the HPLC.
The analysis of these five standard solutions composed of varying levels of estradiol
resulted in five peak areas from similar retention times in the HPLC output (Figure 3.1).
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Figure 3.1 Example of HPLC Output Data

The correlation of concentration to peak area resulted in Pearson r values indicating a
strong, positive relationship each time of blood analysis (Table 3.1). A scatterplot of
concentration versus peak area was created for each measurement of the standard solutions, from
which a prediction equation was determined.

Table 3.1 Relationship of Standard Solution Concentration to Peak Area
Blood Analysis
Measurement 1
Measurement 2
Measurement 3
Measurement 4
Measurement 5

Pearson r
.987
.994
.999
.997
.996
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Significance Level (p)
.006
.001
<.001
<.001
<.001

Retention times within one tenth of a minute to that of the estradiol standard solutions
were considered to be indicative of estrogen within the sample. These retention times and the
corresponding peak areas were recorded. Each sample resulted in one peak area number that was
then plugged into the equation determined from the standard solutions. This raw concentration
value was then multiplied by the dilution factor by which each sample was specifically made.
This final value is the estimated estrogen concentration for the analyzed blood sample.

Olfactory Ability Analysis
The modified WUTC threshold test was evaluated using multiple statistical tests. In total
the threshold test is able to describe each participant’s and group’s olfactory ability in three
distinct ways for each of the four odorants. These measures include threshold, sensitivity and
response bias.
An estimated odorant threshold of each of the odors, vanillin, caraway, spearmint and
muscone was obtained. To determine threshold values the “yes” and “no” responses were
analyzed using logistic regression. The predicted values generated from the logistic regression
were then graphically represented and the estimated threshold value was determined to be the
odorant concentration value that corresponded to a p-value of 0.5 on the sigmoid curve.
To measure olfactory sensitivity the d’ statistic was calculated. The d’ statistic allowed
for a representation of the differences in sensitivity to different odorants. This value is calculated
by determining the difference between the z-scores of the hit and false alarm rates. To be
considered a “hit” an individual must indicate a “yes” during the threshold test when a vial with
an odorant concentration was presented. Inversely, a “false alarm” results when an individual
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responds “yes” when a vial with no odorant is presented. The d’ value was calculated by the
following equation (Macmillan, 1993):
d’=z(H)-z(F)
The values for the d’ statistic range from zero to 4.65 (Tewalt, 2013). The lower the
value, the lower the sensitivity to an odorant, and the higher the value, the more sensitive to an
odorant a participant is thought to be. Sensitivity was calculated for each participant for each of
the four odorants of the threshold test. Their overall sensitivity to all four odorants was also
calculated. Therefore, for one administration each participant produced a total of five sensitivity
values.
As a way to measure the tendency of a person to respond to the presentation of a tube
with either a yes or a no, regardless of whether an odorant was presented or not, response bias
was calculated. The B’’ value is defined by the equation (Stanislaw & Todorov, 1999):

B’’ was calculated as a measure of response bias rather than the standard response bias
measure β due to B’’ independence to the changes in d’ (Stanislaw & Todorov, 1999). A
measurement of response bias was calculated for each participant for both assessments.
To determine respondent reliability, each participant’s response data was split into first
and second administrations for each odor. The reliability statistic Cohen’s kappa was then
computed to determine the reliability of each participant’s dichotomous, “yes”/”no” responses.
Additionally, the reliability for each odorant was calculated.
Demographics collected from each participant were analyzed for the existence of
relationships with all calculated measures.
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Statistical Results
Estrogen Concentration and Olfactory Ability
In order to assess the relationship of estrogen levels (Table 3.2) to olfactory sensitivity
and estimated threshold values linear regressions were employed for each odorant. No significant
differences were found for sensitivity levels for individual odorants. However, there was a trend
for estrogen levels and overall olfactory sensitivity was determined (t = 2.085, p = .074). Two
specific odorant thresholds were determined to be significantly related to and predicted by
estrogen levels in the blood. Spearmint was found to have a moderately strong negative
relationship with estrogen level (r = -.386, p = .001). A significant result of t = -3.359, p = .001
was also found. A second odorant, muscone, was determined to also have a moderately strong
negative relationship (r = -.318, p = .001) with estrogen levels significantly predicting the
threshold levels of both pregnant and non-pregnant participants (t = -3.162, p = .002).

Table 3.2 Estrogen Concentration Levels

Estrogen Concentration Levels

Minimum
(mg/mL)
.01

Maximum
(mg/mL)
21.24

Mean
(mg/mL)
4.28

Std. Dev.
(mg/mL)
4.56

Due to lack of significance in the relationship of individual odorant sensitivity and
estrogen levels, response bias was taken into account. Firstly, it was found that response biases
are moderate to strongly related (r = .623, p < .001) to sensitivity with a significantly predictive
relationship (t = 9.141, p < .001). Response bias per odorant and overall was assessed in
comparison with estrogen levels. Interestingly results indicate a significant, moderately strong
relationship between estrogen concentrations in the blood and overall response bias
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(r = -.404, p < .001), vanillin response bias (r = -.307, p = .002), caraway response bias
(r = -.401, p < .001), spearmint response bias (r =. 348, p = .001), and muscone response bias
(r = .304, p < .001). Thus, when a participant has a response bias to “yes” they tend to also have
relatively elevated blood estrogen levels.
Reliability between each threshold administration test half was assessed with the use of
Cohen’s kappa. The results of the analyses are presented in Table 3.3.

Table 3.3 Reliability Measure between Test Halves (Cohen’s kappa)
Odorant
Vanillin
Caraway
Spearmint
Muscone

Threshold
0.727
0.301
0.643
0.701

Oral Contraceptive and Olfaction
A paired sample t-test was used to assess the differences of olfactory ability between
participants while taking the active hormone pill of their oral contraceptive and while in menses
(i.e., taking the inactive hormone pill). A total of 17 women (27.4%) of the 62 that participated in
both assessments were taking oral contraceptives. To be included in analysis the women selfreported being in menses during one of the two assessment times and not in menses during the
other. No significant differences were found between the mean threshold values or sensitivities
for individual odorants, nor of overall odorant sensitivity.
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Olfactory Abilities during Pregnancy
Changes in olfactory ability throughout pregnancy were analyzed with a one-way withinsubjects analysis of variance. The means and standard deviations for sensitivity and estimated
threshold values are presented in Table 3.3 and Table 3.4 respectively. Vanillin sensitivity
(F (1, 6) = 5.282, p = .049) with a partial eta of 0.568, vanillin threshold (F (1, 6) = 6.274,
p = .046) with a partial eta of 0.611, and muscone threshold (F (1, 6) = 6.681, p = .042) with a
partial eta of 0.627 all significantly changed as women progressed in their pregnancies. This can
be seen in Figures 3.2, 3.3, and 3.4. A trending significance was found for spearmint sensitivity
(F( 1, 6) = 4.16, p = .078), which can be seen in Figure 3.5. It should be noted that there is little
difference between the mean values of the second and third trimesters. This suggests that
olfactory abilities are better in early pregnancy.

Table 3.4 Assessment One and Two Olfactory Sensitivities
Measure
Overall
Vanillin
Caraway
Spearmint
Muscone

Assessment 1
Mean
1.16
2.19
.77
.75
1.09

Std. Dev.
1.14
1.61
.53
.56
1.19

Assessment 2
Mean
.95
1.17
.70
.43
.97

Std. Dev.
1.18
1.06
.45
.63
1.24

Table 3.5 Assessment One and Two Estimated Threshold Values
Measure
Vanillin
Caraway
Spearmint
Muscone

Assessment 1
M
2.97
237.94
671.46
366.34

Std. Dev.
2.75
299.63
1144.98
530.64
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Assessment 2
M
10.61
727.39
1122.33
883.71

Std. Dev.
7.23
1064.05
1483.54
890.73

Figure 3.2 Vanillin Sensitivity During Pregnancy

Figure 3.3 Estimated Vanillin Threshold Values During Pregnancy
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Figure 3.4 Estimated Muscone Threshold Values During Pregnancy

Figure 3.5 Spearmint Sensitivity During Pregnancy
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Pregnant Versus Non-Pregnant
An analysis was conducted to determine if olfactory ability was differed for pregnant and
non-pregnant individuals. Results indicate that there is a significant difference in the threshold
levels of spearmint, with pregnant women having a lower mean estimated threshold (t = 2.097,
p = .006). This difference is also noted with caraway thresholds (t = 2.029, p = .044). To
examine possible explanations a comparison of estrogen levels was made. Overall estrogen
levels seem to be similar during pregnancy to the levels experienced by the women on their
menstrual cycle, with one exception being that women in the first trimester of pregnancy have
slightly higher estrogen levels than non-pregnant participants (t = 1.981, p = .098)

Demographic Relations
Demographic data were also analyzed to determine if any significant correlations existed
between the self-report measure and the olfactory ability measures of sensitivity, threshold and
response bias. Caraway sensitivity was found to be weakly related to instances of self-reported
chronic headaches (r = -.249, p = .036) and high blood pressure (r = -.291, p = .037). Muscone
sensitivity was moderately related to a previous history of cancer (r = -.496, p = .001).
Interestingly spearmint sensitivity is the only odorant sensitivity related to self-reported nose
problems, including having a broken nose (r = -.315, p = .013) and a deviated septum (r = -.281,
p = .026). Each relationship discovered with sensitivity is negative in nature; that is to say that
sensitivity has a trend of being lower in those individuals that are currently or have previously
experienced the aforementioned health related issues.
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Overall response bias and response bias for each individual odorant was noted to be
significant, but weakly relate (p < .05) to a health history of cancer. Individuals that were taking
antihistamines at the time of assessment, as well as those that were experiencing some type of
infection, including sinus infections, were noted to have moderately strong response bias overall
and for each of the four odorants at a significance of p < .05 (Table 3.6)

Table 3.6 Response Bias and Infection
Response Bias and Infection
Vanillin
Caraway
Muscone
Spearmint
Overall

Pearson r
.363
.301
.380
.376
.387

p value
.031
.020
.037
.042
.031

Alternatively, estimated thresholds were compared to self-reported infections with
spearmint threshold. These threshold levels tended to increase, mean ability to smell decreased,
with reported infections. When comparing threshold levels to medications taken at the time of
assessment, muscone threshold levels were moderately, positively related to taking
antidepressant (r = .335, p = .004) and antianxiety (r = .347, p = .007) medications.
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CHAPTER IV
DISCUSSION
The purpose of the current study was to investigate the relationship of estrogen levels on
the olfactory abilities of women. In an attempt to comprehensively understand this possible
relationship, two populations were examined: pregnant and non-pregnant women. Each of these
populations experiences characteristic changes in hormone levels, particularly estrogen, either
during menstruation in non-pregnant women or throughout three trimesters in pregnant
participants. In general, it was found that estrogen levels do, in some fashion, influence olfactory
abilities.
Olfactory ability, as measured by odorant sensitivity, estimated odorant threshold values
and response bias, was seen to change as estrogen levels fluctuated. In fact, a trend of overall
olfactory sensitivity increasing as estrogen levels increased was noted. Given that further
distinctions were found, this expresses that a woman’s ability to sense the presence of an odorant
is, in part, influenced by her hormone levels. To understand what other factors could influence
sensitivity, response bias, was examined for each participant. As expected, response bias
influences an individual’s measured sensitivity. Women with a response bias towards “yes”
tended to have higher reported olfactory sensitivities, while those with a response bias towards
“no” reported a lower sensitivity, or ability, to detect odors.
Potential influences of response bias were examined, and, surprisingly, it was found that
estrogen levels could play a key role. In fact, individual and overall odorant response biases were
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found to have a strong relationship with estrogen levels. This could be a revealing aspect of
hormonal influences on factors outside the specified purview of the olfactory system. As
estrogen levels fluctuate, response biases countered this trend. That is to say that as a woman’s
estrogen levels increased, her response bias decreased. If response bias does not remain the same
for an individual, it is possible that response bias is a mediating factor of estrogen levels and
olfactory sensitivity.
Two odorant thresholds, spearmint and muscone, were found to decrease as estrogen
levels increased. This indicates that as more estrogen circulates through the body, like during the
follicular and luteal phases of menstruation and during the first trimester of pregnancy, a
women’s ability to smell spearmint and muscone is elevated. Due to chiral recognition that
occurs with stereoselective receptors, it is not surprising that one of the enantiomer pairs,
spearmint, is influenced by estrogen levels while caraway seemingly is not. Estrogen levels are
thought to alter the availability of olfactory binding proteins and receptors, but how and in what
magnitude these alterations occur is yet unknown. Results indicate that a woman’s ability to
detect spearmint increases as estrogen levels increase. This could intimate a relationship of
estrogen level influence on specific, stereoselective olfactory binding proteins or receptors.
Muscone, being a non-polar molecule, diffuses across the mucus membrane without the
assistance of olfactory binding proteins. While changes in hormone levels have been shown to
influence the mucus membrane of the uterus, little research has been conducted to investigate if
the mucus membrane of the nasal cavity thins and thickens with any regularity. If the thickness
of the membrane is not a probable cause of the improvement of a woman’s ability to detect
muscone as estrogen levels increase, then, from an evolutionary perspective, the ability to smell
a social odor, like musk, could be a result of a woman’s body preparing for the optimal
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fertilization period. Lundstrom, McClintock, and Olsson (2006) found that oral contraceptive
users experienced greater olfactory sensitivity when inhaling social odors. Despite there being no
relationship between oral contraceptive use and olfactory ability in the current study, it is thought
that the relatively high levels of estrogen could have influenced the distinction between social
and environmental odors, and therefore resulted in the decreased olfactory thresholds for
muscone while estrogen levels were relatively high.
Wohlgemuth, et. al. (2008) found that pregnant women self-reported heightened olfactory
sensitivity to multiple odors, including those prominently composed of musk-like components.
Little research has been conducted to examine if an objective change in olfactory ability occurs
once pregnant, or if it is simply a perceived self-report phenomenon. In the current study it was
found that, in fact, there is a difference in olfactory ability as measured by odorant sensitivity and
estimated threshold values, for some odorants, between pregnant and non-pregnant participants.
In general, it was determined that estrogen levels of the women in their first trimester of
pregnancy superseded those of non-pregnant women. These higher level of estrogen indicate the
expected lower mean thresholds of spearmint and caraway in the pregnant participants.
Self-report changes in olfactory perception show pregnant women reporting several
changes, many of which relate to the odor qualities of spearmint and caraway. The odor of minty
toothpaste is one of the most commonly reported stimulant causes of morning sickness during
pregnancy (Wohlgemuth, et. al., 2008). Also, pungent and mildew-like odors have been reported
to smell more strongly and perceived as more negative in pregnant populations (OchsenbeinKölble, et. al., 2007). These self-reported heightened sensitivities to mint and stale type odors
could in fact be due to a measureable difference in a pregnant women’s ability to smell.
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It has been postulated that olfactory ability might be improved for toxic or harmful odors,
especially during the first trimester of fetal development, to possibly hinder any negative
influences that could cause developmental issues during this rapid growth period. To resolve if
olfactory abilities remained heightened throughout pregnancy, participants were assessed at two
time points within pregnancy. It was found that during the first trimester vanillin sensitivities and
thresholds, as well as muscone thresholds, all were heightened when compared to the second and
third trimesters. It has been concluded that while olfactory ability does improve for a short time
during pregnancy, the first trimester is the only time that this occurs. It is thought that the
olfactory abilities during the second and third trimesters more closely resemble that of nonpregnant women.
Through the examination of demographic data, further relationships of olfactory ability
were discovered. It was found that odorant sensitivity is related to numerous health issues.
Spearmint sensitivity was found to significantly relate to having a previously broken nose or a
deviated septum. This is unsurprising due to the changes the nasal cavity experiences due to
these physical alterations. For example, a previously broken nose or deviated septum could result
in less air flow across the mucosal membrane, thus preventing an adequate amount of odorant to
readily diffuse across the membrane for interpretation. Caraway sensitivity was found to be
weakly related to both high blood pressure and reports of chronic headaches. High blood
pressure can result in a thickening of the nasal mucosa and a development of persistent or
chronic headaches. In addition, chronic headaches can yield symptoms of swelling of nasal
epithelium and the thickening of the nasal mucus membrane (Chow, 1993). In both instances,
odorants could encounter diffusion or binding problems.
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Muscone was noted to have a moderate relationship with cancer, it is unclear why cancer
would influence muscone sensitivity specifically. Knowing the type of cancer could shed further
light on the relationship, but was outside of the scope of the provided demographic. Estrogen has
been found to stimulate breast tissue cell growth and to influences certain blood vessel cancers,
vaginal cancer, and melanoma (Ito, Utsunomiya, Yaegashi & Sasano, 2007).
A history of cancer was also related to response bias, as well as those suffering from an
infection at the time of assessment. It is thought that individuals suffering from some type of
infection, particularly those infections resulting in cold or allergy like symptoms, would, as
found, have an increased response bias towards yes. Participants often want to do well on a given
assessment, but, when they perceive their abilities to be stunted by environmental factors, like a
cold, during a test that is assessing one’s ability to smell, many participants seemed to
compensate by indicating a “yes” more often than they actually smelled an odorant. Despite this
response bias towards responding “yes”, spearmint threshold levels still tended to increase in
those with self-reported infections.
When comparing threshold levels to medications taken at the time of assessment it was
found that individuals taking anti-anxiety and anti-depressant medications had higher muscone
threshold levels. Areas of the brain that are involved in depression also overlap with areas
responsible for olfactory perception (Naudin, El-Hage, Gomes, Gaillard, Belzung, & Atanasova,
2012). Assuming individuals taking anti-depressant medications have been diagnosed with
depression, this overlap in brain region could explain why, when depression is present, olfactory
abilities are not as acute as they could be.
A final significant relationship was found when examining medication and olfactory
abilities. It was found that taking antihistamines related to response bias overall and for each
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individual odorant. This can again be attributed to a participants attempt to be perceived as
performing well. It stands to reason that an individual taking antihistamines is most likely
suffering from allergy or cold-like symptom. If they are experiencing nasal congestion, but want
to be perceived as doing well on an olfactory test, their response bias is expected to shift, as it
did in the current study. Surprisingly, having seasonal allergies did not show a relationship with
olfactory ability. However, because assessment one was conducted in late November and
assessment two was conducted in mid-December, very few, if any, seasonal allergies would have
been present in the external environment.
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CHAPTER V
CONCLUSIONS
Overall, differences were found in the various measures of olfactory ability implemented
in the current study, leading to the conclusion that hormone levels, specifically estrogen, do
influence olfactory abilities.

Limitations and Directions of Future Research
Assessment Time
While the sample size for non-pregnant participants in the current study is one of the
largest known samples, a major limitation to analysis, was the number of times participants were
assessed. Each participant, pregnant and non-pregnant alike, was assess twice. Each pregnant
participant was assessed six weeks from time one and time two in the hopes of allowing for two
distinct time measurements across two different trimesters of each of their pregnancies. The nonpregnant participants were assessed a total of three weeks apart from time one to time two. While
this allowed for a distinction to be made between phases of the menstrual cycle and estrogen
levels to naturally differ, some participants were assessed at the same time in their cycle while
other participants did not uniformly progress through the menstrual cycle. This led to many
individuals changing treatment group in a non-uniform fashion, thus limiting statistical analyses.
In the future, to gain a better understanding of the exact relationship between estrogen
level fluctuations during the menstrual cycle and changing olfactory abilities, it would be prudent
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to be able to classify each individual by what stage of the menstrual cycle in which they begin
the study. Grouping individuals this way would allow for better control and determination of
when a second assessment should occur.
Furthermore, both pregnant and non-pregnant women should be assessed a minimum of
three times. In the current study, resource and time factors limited the scope to two separate
assessments. However, in the future measuring olfactory abilities and estrogen levels during each
trimester and in each phase of women’s menstrual cycle will allow for a more precise
representation of how hormone levels, hormone type, and olfactory ability fluctuate.

Statistical Analysis
With the limited sample of many of the reported demographic selections, the
relationships described could be due to chance. The demographic and olfactory ability
relationships reported, while significant at an alpha level of .05, could be viewed in a more
conservative manner to more accurately assess actual relationships. When looking further into
possible relationships between demographic data and olfactory ability, focusing on and
increasing the sample size directionally to include people with specifically highlighted previous
health histories (e.g., cancer) could be beneficial.

Blood Analysis
Analyzing the blood with the HPLC was a good first step in analysis. However, the peak
areas determined from the HPLC output did vary in both retention time and area when compared
to the standard solutions. This is most likely due to other small molecules being present and
detected. Centrifugation only allows for separation up to a certain size molecule. Estrogen is not
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the smallest molecule in the blood, nor is it the only small molecule present in our blood. In
addition to other hormones, there are several other possible steroids, proteins and lipids that
could be present.
In the future, blood samples should be analyzed as was done in the current study, but the
analysis should be lengthened. Due to time and logistic constraints only a single one milliliter
sample of blood was analyzed from each tube. For the most representative filtrate mixture of a
person’s blood contents, three one milliliter samples should be drawn, centrifuged, and then
combined and diluted in preparation for HPLC analysis. Once a retention time has been recorded
for a sample similar to that of the standard solutions, that sample should be run back through the
column and the material corresponding to the peak area measurements should be extracted for
further analysis. This further analysis could include mass spectrometry analysis to assess the
extracted samples contents by molecular weight.
Also, estrogen was the only hormone examined in this study, yet there are many
hormones that are present and fluctuate in the blood during menstruation and pregnancy. Once a
procedure for exact analysis has been finalized for estrogen, the project can then be expanded to
the analysis of blood estrogen levels to that of progesterone, luteinizing hormone, follicle
stimulating hormone, and even gonadotropin releasing hormone.
In addition to examining other hormones, extending the scope of research to investigate
disease, infection, and environmental biomarker relationships to and influence on olfactory
ability is the next step in this area of research. Biomarkers have been found to be indicative of
many biological and psychological conditions (Aronson, 2005). In turn, biomarkers could be
employed from the external environment. If bound to specific odorants, biomarkers could be
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used as a tracking system, allowing for a better understanding of the specific nuanced differences
between how odorants travel within the olfactory system.

Measurement of Olfactory Ability
In the current study olfactory ability was assessed using objective measurements of
estimated thresholds, sensitivity, and response bias. While the modified WUTC allows for a
comprehensive assessment of olfactory sensitivity, it does not assess the totality of olfactory
ability. A measure could be included to assess if odor identification changes in conjunction with
olfactory sensitivity and hormone levels. Participants spent on average from one hour to two
hours per assessment participating in this research. While adding a lengthy measure of odor
identification ability would be cumbersome, and even counterproductive, possibly causing
participant fatigue, adding a relatively short measure like the University of Pennsylvania Smell
Identification Test (Doty, Shaman, Kimmelman, & Dann, 1984) could be beneficial in yielding a
more comprehensive look at the changes experienced in the olfactory system.

Nature of This Research
This research contributes to the current breadth of knowledge in a profound way.
Previous research indicates that this is the first of its kind to compare blood hormone levels to
the olfactory abilities of pregnant women. Much of the current knowledge concerning if and how
olfaction changes during pregnancy is based in subjective measures of self-report. This has led to
findings being heterogeneous and inconclusive. The current study is a first step in the direction
of an objective understanding of how olfaction might be influenced throughout pregnancy.
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Furthermore, beyond studies that have used self-report survey measures as a means of
assessment, this study is one of the largest to assess the non-pregnant female population’s
olfactory abilities in conjunction with any measure of hormone fluctuation or stage of the
menstrual cycle. In addition, the WUTC has allowed for assessment to incorporate and
investigate four distinct odorants. Previous research involving threshold and sensitivity measures
has been limited to single odorant specifications. By assessing multiple odorants, the current
study was able to compare and contrast the possible differences of how each odorant is processed
within the olfactory system. In turn, this research has allowed for the finding that estrogen
influences some of the fluctuations in olfaction seen in non-pregnant and pregnant populations.
The magnitude and depth of this research has been a result of interdisciplinary
cooperation – a component that has only strengthened the level of inquiry possible. Future
research should attempt to incorporate multiple disciplines in the discovery, research, and
refinement of what is known and unknown regarding the chemical senses in humans.
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Vanillin:

Caraway:

Spearmint:

Muscone:
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Demographics Questionnaire
Age (in years): _________
Gender (circle one):

Male

Female

If female, please also answer the questions located on the last page. ***
Ethnicity (circle one):
Bi-Racial

Caucasian

African American

Asian

Latino

Other (please indicate): _______________________________

Do you currently smoke (circle one):

Yes

No

Yes

No

If not currently smoking/using tobacco products, have you ever used either? (Circle one): Yes

No

If yes, how many cigarettes per day?_____ Cigars per day?____
What type of cigarettes do you smoke? __________________________
How many years have you smoked? ______________
Do you currently use other tobacco products? (Circle one):
If yes, what quantity per day?_______
What type of tobacco product do you use? ________________________
How many years have you used tobacco? _______________

If yes, how long ago did you stop?_______
How many cigarettes did you smoke per day?_____; Cigars per day?_____
What type of tobacco product did you use? _________________________
Did your ability to smell change after you stopped using tobacco? (Circle one):

Yes

If yes, how? ____________________________________________

What is your current occupation: _______________________________________________

Highest grade completed? (Circle only one number):
Grade School:
Years of College:

6

7
1

8
2

9
3

10
4

5
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11
6+

12

No

Please indicate if you have had past history of the following medical illnesses. (Circle Yes or No):

High blood pressure

Yes

No

Diabetes

Yes

No

Arthritis

Yes

No

Heart disease

Yes

No

Thyroid disorder

Yes

No

Chronic Headaches

Yes

No

Lung trouble

Yes

No

Gout

Yes

No

Epilepsy

Yes

No

Circulation problems

Yes

No

Broken nose

Yes

No

Anemia

Yes

No

Strokes

Yes

No

Eye disease (e.g. Glaucoma)

Yes

No

Asthma

Yes

No

Cancer

Yes

No

Please indicate if you have had past history of the following medical illnesses. (Circle Yes or No):

Hepatitis

Yes

No

Ulcer

Yes

No

Hiatal hernia

Yes

No

Kidney disease

Yes

No

Sleep Apnea

Yes

No

Skin disease

Yes

No

Prostate problems

Yes

No

Infections

Yes

No

Bleeding/clotting disorder

Yes

No

HIV

Yes

No

TB

Yes

No

Neurological disease

Yes

No

Food allergies

Yes

No

Sinus problems

Yes

No

Medical allergies

Yes

No

Deviated septum

Yes

No

Seasonal allergies

Yes

No

Concussion/head trauma

Yes

No

Specific Allergy(ies): _________________________________________________________________
Other medical illness(es): ______________________________________________________________
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Please indicate if you are currently taking any of the following types of medications or vitamins.
(Circle Yes or No):
Antibiotics

Yes

No

Antidepressants

Yes

No

Lithium

Yes

No

Antianxiety

Yes

No

Blood Pressure

Yes

No

Hormone replacements

Yes

No

Antihistamines

Yes

No

Pre-Natal Vitamins/DHA

Yes

No

Anti-inflammatory†

Yes

No

Yes

No

†

Including ibuprofen

Antineoplastic††
††

Examples of Antineoplastics are Elspar (asparaginase), Alkeran (melphalan), floxuridine,
lomustine, procarbazine, thioguanine, thiotepa
Stimulant medications†††
†††

Yes

No

Examples of Stimulant medications are Adderall and Vyvanse

***Females (optional, but each question is VERY BENEFICIAL to answering research questions)
If FEMALE: What is the date of the first day of your most recent period? _____________________
If FEMALE: What is the date of the last day of your most recent period (use today’s date if you are
currently menstruating)? _________________________
If FEMALE: Are you currently taking birth control? (Circle one):

Yes

No

If yes, what type (e.g. oral contraception, IED, patch, etc.)? __________________________
If yes, what brand of birth control are you using (e.g. Yaz, Apri, etc.)? _________________
If yes, how long have you been taking birth control? _______________________________
If FEMALE: Are you currently pregnant? (Circle one):

Yes

No

Yes

No

If yes, how many weeks pregnant are you? ________________
If known, what was your conception date? ________________
If known, what is your expected due date? ________________
If known, what sex is your child? _______________________
If FEMALE: Have you had a previous pregnancy? (Circle one):
If yes, how many previous pregnancies have you had? __________________
Of that/those, how many pregnancies resulted in a live birth?____________
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INFORMED CONSENT FORM (Threshold Test)
Odor Sensitivity and Hormone Levels
Please read this consent document carefully before you decide to participate in this study. The
Institutional Review Board of the University of Tennessee at Chattanooga (FWA00004149) has
approved this research project #13-139.
Purpose of the research study:
The purpose of this study is to measure odor sensitivity in healthy female, pregnant and nonpregnant, adults.
What you will be asked to do in the study:
You will initially be asked to complete a brief demographics page. A researcher will then begin
the threshold test by presenting a tube filled with clear liquid beneath your nose for 5 seconds.
After these 5 seconds have passed, you will be given 10 seconds to tell the researcher “yes” (you
did detect an odor) or “no” (you did not detect an odor). The test contains 54 tubes with various
odors and concentrations, although not all of the tubes will contain odors.
Time required:
~ 45 minutes
Risks and Benefits:
You may experience some nasal dryness from prolonged smelling. We do not anticipate any
direct benefit from the study, but we do appreciate your participation as this will add to a
growing body of research that will benefit others in the future.
Compensation:
A nontransferable gift card will be issued to you during the second portion of your participation
in this study.
Confidentiality:
Your identity will be kept confidential to the extent provided by law. Your information will be
assigned a code number. The list connecting your name to this number will be kept in a locked
file in my research office to which only I and my other research team members have access.
When the study is completed and the data have been analyzed, the list will be destroyed. Your
name will not be used in any report.
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Voluntary participation:
Your participation in this study is completely voluntary. There is no penalty for not participating.
Right to withdraw from the study:
You have the right to withdraw from the study at any time without consequence.
Whom to contact if you have questions about the study:
Carrie LeMay (344 Holt Hall, 423-506-5987 and carrie.lemay@utc.edu)
William Tewalt (344 Holt Hall, wtewalt@gmail.com)
Dr. Nicky Ozbek (350 Holt Hall, 425-4285 and Nicky-Ozbek@utc.edu).
Agreement:
I have read the procedure described above. I voluntarily agree to participate in the procedure and
I have received a copy of this description.
Participant Signature: ____________________________________ Date: _________________
Printed Name: __________________________________________
If you have any questions about your rights as a subject/participant in this research, or if you
feel you have been placed at risk, you can contact Dr. Bart Weathington, Chair of the
Institutional Review Board, at 423-425-4289. Additional contact information is available at
www.utc.edu/irb

59

APPENDIX E
BLOOD DRAW INFORMED CONSENT

60

INFORMED CONSENT FORM (Blood Donation)
Odor Sensitivity and Hormone Levels
Please read this consent document carefully before you decide to participate in this study. The
Institutional Review Board of the University of Tennessee at Chattanooga (FWA00004149) has
approved this research project #13-139.
Purpose of the research study:
The purpose is to determine various hormone levels in the blood samples.
What you will be asked to do in the study:
You will be asked to provide a sample of blood that will be stored for later analysis in the
determination of hormone levels.
Time required:
~30 minutes
Risks and Benefits:
Donors will be screened for previously diagnosed allergic response to mild volatile chemicals.
Subjects will be exposed to hypodermic needles.
Compensation:
No direct compensation will be given.
Confidentiality:
Your identity will be kept confidential to the extent provided by law. Your information will be
assigned a code number. The list connecting your name to this number will be kept in a locked
file in my office to which only I and my other research team members have access. When the
study is completed and the data have been analyzed, the list will be destroyed. Your name will
not be used in any report.
Voluntary participation:
Your participation in this study is completely voluntary. There is no penalty for not participating.
Right to withdraw from the study:
You have the right to withdraw from the study at any time without consequence.
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Whom to contact if you have questions about the study:
Carrie LeMay (344 Holt Hall, 423-506-5987 and carrie-lemay@utc.edu)
Dr. Manuel F. Santiago (615 McCallie Avenue, 425-5364 and Manuel-Santiago@utc.edu).
Agreement:
I have read the procedure described above. I voluntarily agree to participate in the procedure and
I have received a copy of this description.
Participant Signature: ____________________________________ Date: _________________
Printed Name: __________________________________________
If you have any questions about your rights as a subject/participant in this research, or if you
feel you have been placed at risk, you can contact Dr. Bart Weathington, Chair of the
Institutional Review Board, at 423-425-4289. Additional contact information is available at
www.utc.edu/irb
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Phlebotomy educational material and consent
Thank you for allowing us to collect your blood today. We would like to explain the risks of
donating tubes of blood and allow you to ask any questions. Donating blood is not risk free. If
you do not feel well, then notify an employee.
What are the possible adverse effects of blood donation?
Pain, redness, swelling and bruising and rarely phlebitis, vascular injury, local infection, muscle
or tissue damage, and scarring. Anxiety, fever, headache, lightheadedness, paleness, sweating,
chills, nausea, vomiting, dizziness, excessive tiredness, weakness, hyperventilation, itching,
hives, low blood pressure and fainting. Fainting or loss of consciousness following donation can
cause the donor to fall which can lead to physical injuries with long-term complications
including death. Other rare and severe symptoms can include seizures, incontinence, chest pain,
respiratory problems including shortness of breath, difficulty breathing, a severe allergic
reaction, tetany and cardiac arrhythmia.
What should I do after donating the tubes of blood?
•
•

•
•

•
•

Eat and drink in the recovery area. Sit for 15 minutes before leaving.
Leave the adhesive bandage around the arm for 1 hour and the Band-Aid on for 4 hours.
If the needle site bleeds, apply firm pressure over the bandage and raise the arm for 5-10
minutes.
Avoid strenuous activities such as participating in team sports, lifting, pushing or picking
up heavy objects for 4-5 hours after donating.
Apply ice if a bruised area appears on the arm. The ice should be applied periodically for
10-15 minutes for the first 24 hours following donation. In subsequent days, periodically
apply warm moist heat to the area. The area may be discolored for 10 days or more.
If you feel dizzy or lightheaded, do not drive. Sit down and lower the head or lie down,
keeping the head lower than the rest of the body if you feel dizzy.
Call us at 1-800-962-0628 or 423-756-0966 if dizziness persists, or if any other problems
occur after donation.

I understand that I am about to have blood drawn from my arm (phlebotomy). My blood will be
used for research purposes. I have been given the opportunity to ask questions and can withdraw
my consent at any time.
Donor Signature: ____________________________________________ Date:_____________
Print:
First Name:__________________Print MI _______Last____________________Suffix _____
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